Indaptus Therapeutics, Inc.
INDP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857044
No open-market purchases or sales by Indaptus Therapeutics, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.15M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Indaptus Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Indaptus Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lazar David E. | Director | – | Mar 24, 2026 | 1 |
| Jabbour Jerome D | Director | – | Feb 27, 2026 | 1 |
| Meckler Jeffrey A | Co-Chief Executive Officer | 229,929 | Feb 13, 2026 | 2 |
| Natan David | Director | – | Jan 22, 2026 | 1 |
| Ben-Tzvi Avraham | Director | 25,100 | Jan 22, 2026 | 1 |
| Linscott Walt Addison | Chief Operating Officer | 54,426 | Dec 29, 2025 | 1 |
| Sassi Nir | Chief Financial Officer | 26,758 | Dec 29, 2025 | 1 |
| Newman Michael James | CSO and Director | 101,074 | Dec 29, 2025 | 1 |
| Hayes William B | Director | – | Jun 11, 2025 | 0 |
| Martell Robert | Director | – | Jun 11, 2025 | 0 |
| Maddaluna Anthony J | Director | – | Jun 11, 2025 | 0 |
| Pomerantz Roger | Director | – | Jun 11, 2025 | 0 |
| Karah Hila | Director | – | Jun 11, 2025 | 0 |
| Gilbert Mark John | Director | – | Jun 11, 2025 | 0 |
| Waltzman Roger J. | Chief Medical Officer | – | Oct 10, 2024 | 0 |
| Anderson Glen R. | 10% Owner | 1,190,400Indirect | Aug 16, 2023 | 0 |
| Litchev Boyan Vesselinov | Chief Medical Officer | 1,150 | Dec 19, 2022 | 0 |
| O'Callaghan Brian | Director | – | Oct 3, 2022 | 0 |
| Lee Hoonmo | Director | – | Aug 6, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 (view filing) | Mar 23 | 1 day | Lazar David E.Director | SSale | −108.9M | – | – | –0 after | Derivative2 lots |
| Aug 16, 2023 (view filing) | Aug 10-14 | 6 daysLate | Anderson Glen R.10% Owner | PPurchase | +103.4K | $2.09 | +$216.4K | +9.5%1.19M after | 3 lots |
| Dec 19, 2022 (view filing) | Jan 31-Dec 1 | 322 daysLate | Litchev Boyan VesselinovChief Medical Officer | PPurchase | +1.15K | $2.19 | +$2.52K | New position1.15K after | 4 lots |
| Nov 22, 2022 (view filing) | Nov 18-21 | 4 days | Meckler Jeffrey ACEO and Director | PPurchase | +10.0K | $1.89 | +$18.9K | +15.3%75.4K after | 2 lots |
| Sep 12, 2022 (view filing) | Sep 8 | 4 days | Meckler Jeffrey ACEO and Director | PPurchase | +10.3K | $2.80 | +$28.9K | +18.7%65.4K after | |
| Sep 9, 2022 (view filing) | Sep 7 | 2 days | Linscott Walt AddisonChief Business Officer | PPurchase | +150 | $2.62 | +$393 | New position150 after | |
| Sep 8, 2022 (view filing) | Sep 6-7 | 2 days | Meckler Jeffrey ACEO and Director | PPurchase | +9.69K | $2.56 | +$24.8K | +21.4%55.1K after | 2 lots |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Meckler Jeffrey ACEO and Director | PPurchase | +19.7K | $2.63 | +$51.9K | +76.9%45.4K after | |
| Feb 2, 2022 (view filing) | Jan 31-Feb 1 | 2 days | Newman Michael JamesCSO and Director | SSale | −20.0K | $5.00 | −$100.0K | −1.4%1.37M after | 2 lots |
| Nov 19, 2021 (view filing) | Nov 18 | 1 day | Meckler Jeffrey ACEO and Director | PPurchase | +11.2K | $5.82 | +$65.1K | +77.4%25.6K after | |
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Meckler Jeffrey ACEO and Director | PPurchase | +12.0K | $7.00 | +$84.0K | +487.8%14.5K after |